HERON THERAPEUTICS, INC. /DE/ (HRTX) reporting calendar
HERON THERAPEUTICS, INC. /DE/ files periodic reports with the SEC as HRTX on Nasdaq. Atlas tracks 61 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 29 Jul 2026 – 20 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 11 May 2026
- Reports on record
- 61
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open HRTX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 11 May 2026 | 41 days | 0001193125-26-215755 |
| 10-K | 31 Dec 2025 | 26 Feb 2026 | 57 days | 0001193125-26-073515 |
| 10-Q | 30 Sep 2025 | 4 Nov 2025 | 35 days | 0001193125-25-263618 |
| 10-Q | 30 Jun 2025 | 8 Aug 2025 | 39 days | 0000950170-25-105475 |
| 10-Q | 31 Mar 2025 | 6 May 2025 | 36 days | 0000950170-25-063971 |
| 10-K | 31 Dec 2024 | 27 Feb 2025 | 58 days | 0000950170-25-028374 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0000950170-24-124698 |
| 10-Q | 30 Jun 2024 | 6 Aug 2024 | 37 days | 0000950170-24-091764 |
| 10-Q | 31 Mar 2024 | 7 May 2024 | 37 days | 0000950170-24-053964 |
| 10-K | 31 Dec 2023 | 12 Mar 2024 | 72 days | 0000950170-24-029951 |
| 10-Q | 30 Sep 2023 | 14 Nov 2023 | 45 days | 0000950170-23-063714 |
| 10-Q | 30 Jun 2023 | 14 Aug 2023 | 45 days | 0000950170-23-042431 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0000950170-23-021237 |
| 10-K | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0000950170-23-010603 |
| 10-Q | 30 Sep 2022 | 8 Nov 2022 | 39 days | 0001564590-22-037047 |
| 10-Q | 30 Jun 2022 | 9 Aug 2022 | 40 days | 0001564590-22-028599 |
| 10-Q | 31 Mar 2022 | 9 May 2022 | 39 days | 0001564590-22-018877 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0001564590-22-007618 |
| 10-Q | 30 Sep 2021 | 3 Nov 2021 | 34 days | 0001564590-21-053953 |
| 10-Q | 30 Jun 2021 | 9 Aug 2021 | 40 days | 0001564590-21-042362 |
| 10-Q | 31 Mar 2021 | 10 May 2021 | 40 days | 0001564590-21-025796 |
| 10-K | 31 Dec 2020 | 24 Feb 2021 | 55 days | 0001564590-21-007841 |
| 10-Q | 30 Sep 2020 | 5 Nov 2020 | 36 days | 0001564590-20-050911 |
| 10-Q | 30 Jun 2020 | 5 Aug 2020 | 36 days | 0001564590-20-036822 |
| 10-Q | 31 Mar 2020 | 6 May 2020 | 36 days | 0001564590-20-021575 |
| 10-K | 31 Dec 2019 | 2 Mar 2020 | 62 days | 0001564590-20-007973 |
| 10-Q | 30 Sep 2019 | 12 Nov 2019 | 43 days | 0001564590-19-042638 |
| 10-Q | 30 Jun 2019 | 5 Aug 2019 | 36 days | 0001564590-19-028537 |
| 10-Q | 31 Mar 2019 | 9 May 2019 | 39 days | 0001193125-19-142333 |
| 10-K | 31 Dec 2018 | 22 Feb 2019 | 53 days | 0001193125-19-047780 |
| 10-Q | 30 Sep 2018 | 7 Nov 2018 | 38 days | 0001193125-18-320941 |
| 10-Q | 30 Jun 2018 | 8 Aug 2018 | 39 days | 0001193125-18-242064 |
| 10-Q | 31 Mar 2018 | 10 May 2018 | 40 days | 0001193125-18-158506 |
| 10-K | 31 Dec 2017 | 27 Feb 2018 | 58 days | 0001193125-18-060951 |
| 10-Q | 30 Sep 2017 | 6 Nov 2017 | 37 days | 0001193125-17-333663 |
| 10-Q | 30 Jun 2017 | 9 Aug 2017 | 40 days | 0001193125-17-252860 |
| 10-Q | 31 Mar 2017 | 10 May 2017 | 40 days | 0001193125-17-165100 |
| 10-K | 31 Dec 2016 | 23 Feb 2017 | 54 days | 0001193125-17-054088 |
| 10-Q | 30 Sep 2016 | 8 Nov 2016 | 39 days | 0001193125-16-763038 |
| 10-Q | 30 Jun 2016 | 8 Aug 2016 | 39 days | 0001193125-16-675250 |
Source: SEC EDGAR company submissions for CIK 0000818033. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.